DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Torsemide (Torsemide) - Life Threatening Events - Suspected Cause - Side Effect Reports

 
 



Index of reports > Life Threatening Events (43)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Torsemide life threatening events. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 43   Next >>

Possible Torsemide side effects in 61 year old female

Reported by a physician from Germany on 2012-08-27

Patient: 61 year old female, weighing 70.0 kg (154.0 pounds)

Reactions: Hepatotoxicity, Presyncope

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Clopidogrel Bisulfate
    Dosage: 75 milligram
    Indication: Prophylaxis

Dexamethasone
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2011-02-24
    End date: 2011-03-17

Allopurinol
    Dosage: 300 milligram

Dexamethasone
    Dosage: 40 milligram
    Administration route: Oral
    Start date: 2011-03-10
    End date: 2011-03-17

Revlimid
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2011-02-24
    End date: 2011-03-16

Pantoprazole
    Dosage: 40 milligram

Acyclovir
    Dosage: 400 milligram

Torsemide
    Dosage: 10 milligram
    Indication: Hypertension

Enalapril Maleate
    Dosage: 10 milligram

Other drugs received by patient: Amitriptyline HCL; Trimethoprim + Sulfamethoxazole; Valoron; Amitriptyline Hydrochloride; Lyrica; Enoxaparin Sodium; Moviprep; Soventol Gel; Folsan; Morphine; Morphine; Valoron; Cotrim DS



Possible Torsemide side effects in 75 year old male

Reported by a physician from Switzerland on 2012-08-27

Patient: 75 year old male, weighing 88.0 kg (193.6 pounds)

Reactions: Myoclonus, Drug Level Increased, Renal Failure Acute

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Lasix
    Administration route: Oral
    Start date: 2012-03-13
    End date: 2012-04-07

Vancocin Hydrochloride
    Start date: 2012-04-07
    End date: 2012-04-21

Lasix
    Administration route: Oral
    Start date: 2012-04-09
    End date: 2012-04-16

Tramadol Hydrochloride
    Start date: 2012-03-13
    End date: 2012-03-14

Duragesic-100
    Start date: 2012-04-11
    End date: 2012-04-19

Citalopram Hydrobromide
    Administration route: Oral
    Start date: 2012-04-03

Cefepime Hydrochloride
    Start date: 2012-04-07
    End date: 2012-04-21

Lasilacton
    Administration route: Oral
    Start date: 2012-04-07

Torsemide
    Administration route: Oral
    Start date: 2012-04-17

Morphine Hydrochloride
    Dosage: dose 2%
    Start date: 2012-03-13

Other drugs received by patient: Cozaar; Marcumar; Novalgin; Allopurinol; Perenterol; Motilium; Fragmin; Pipamperone; Nitroderm; Lyrica; Acetaminophen; Navoban; Pantoprazole; Droperidol; Konakion; Fragmin; Ondansetron; Levothyroxine Sodium; Metoprolol Tartrate; Loperamide HCL; Moviprep; Folvite



Possible Torsemide side effects in 75 year old male

Reported by a health professional (non-physician/pharmacist) from Switzerland on 2012-08-20

Patient: 75 year old male, weighing 88.0 kg (193.6 pounds)

Reactions: Myoclonus, Drug Level Increased, Renal Failure Acute

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Lasix
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-04-09
    End date: 2012-04-16

Morphine
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-03-13

Vancocin Hydrochloride
    Indication: Intervertebral Discitis
    Start date: 2012-04-07
    End date: 2012-04-21

Lasix
    Administration route: Oral
    Start date: 2012-03-13
    End date: 2012-04-07

Duragesic-100
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-04-11
    End date: 2012-04-19

Citalopram Hydrobromide
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-04-03

Tramadol Hydrochloride
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-03-13
    End date: 2012-03-14

Lasilactone
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-04-07

Torsemide
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-04-17

Cefepime
    Indication: Intervertebral Discitis
    Start date: 2012-04-07
    End date: 2012-04-21

Other drugs received by patient: Metoprolol Tartrate; Moviprep; Dalteparin Sodium; Dalteparin Sodium; Novalgin; Folvite; Marcumar; Acetaminophen; Lyrica; Navoban; Cozaar; Imodium; Perenterol; Ondansetron; Dipiperon; Nitroderm; Motilium; Levothyroxine Sodium; Allopurinol; Konakion; Droperidol; Pantoprazole



Possible Torsemide side effects in 87 year old male

Reported by a physician from United States on 2012-08-08

Patient: 87 year old male, weighing 84.8 kg (186.6 pounds)

Reactions: Renal Failure

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Spironolactone
    Indication: Cardiac Failure Congestive
    Start date: 2009-01-21

Zaroxolyn
    Indication: Cardiac Failure Congestive
    Start date: 2012-01-29

Torsemide
    Indication: Cardiac Failure Congestive
    Start date: 2010-08-25

Tafamidis Meglumine
    Administration route: Oral
    Indication: Amyloidosis
    Start date: 2008-12-05

Other drugs received by patient: Ambien; Synthroid; Coumadin; Lipitor; Allopurinol; Colchicine; Colchicine



Possible Torsemide side effects in 87 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-31

Patient: 87 year old male, weighing 84.8 kg (186.6 pounds)

Reactions: Renal Failure, Cardiac Failure Congestive

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Spironolactone
    Dosage: 12.5 mg (12.5 mg,1 in 1 d),oral
    Administration route: Oral
    Indication: Cardiac Failure Congestive
    Start date: 2009-01-21

Torsemide
    Dosage: 200 mg (100 mg,2 in 1 d),oral
    Administration route: Oral
    Indication: Cardiac Failure Congestive
    Start date: 2010-08-25

Tafamidis Meglumine
    Dosage: 20 mg (20 mg, 1 in 1 d),oral
    Administration route: Oral
    Indication: Amyloidosis
    Start date: 2008-12-05

Zaroxolyn
    Dosage: as needed (2.5 mg),oral
    Administration route: Oral
    Indication: Cardiac Failure Congestive
    Start date: 2010-01-29

Other drugs received by patient: Ambien; Synthroid; Colchicine; Lipitor; Allopurinol; Coumadin



Possible Torsemide side effects in male

Reported by a physician from Germany on 2012-07-31

Patient: male

Reactions: Loss of Consciousness

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Xarelto
    Dosage: 10 mg, hs
    Administration route: Oral
    Indication: Knee Arthroplasty

Arcoxia
    Administration route: Oral
    Indication: Pain

Bisoprolol Fumarate
    Administration route: Oral
    Indication: Hypertension

Opium Alkaloids and Derivatives
    Indication: Product Used FOR Unknown Indication

Ramipril
    Administration route: Oral
    Indication: Hypertension

Amitriptyline HCL
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Torsemide
    Administration route: Oral
    Indication: Diuretic Therapy

Amlodipine
    Administration route: Oral
    Indication: Hypertension

Voltaren
    Administration route: Oral
    Indication: Pain

Pantoprazole
    Administration route: Oral
    Indication: Gastric Disorder

Targin
    Indication: Pain

Alfuzosin
    Administration route: Oral
    Indication: Prostatic Disorder



Possible Torsemide side effects in 87 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-23

Patient: 87 year old male, weighing 84.8 kg (186.6 pounds)

Reactions: Renal Failure, Peritoneal Dialysis, Condition Aggravated, Cardiac Failure Congestive

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Zaroxolyn
    Indication: Cardiac Failure Congestive
    Start date: 2012-01-29

Spironolactone
    Indication: Cardiac Failure Congestive
    Start date: 2009-01-21

Torsemide
    Indication: Cardiac Failure Congestive
    Start date: 2010-08-25

Tafamidis Meglumine
    Dosage: 20mg (20 mg, 1 in 1 d),oral
    Administration route: Oral
    Indication: Amyloidosis
    Start date: 2008-12-05

Other drugs received by patient: Ambien; Warfarin Sodium; Colchicine (Colchidine); Allopurinol; Synthroid; Lipitor



Possible Torsemide side effects in 46 year old female

Reported by a physician from United States on 2012-06-29

Patient: 46 year old female, weighing 180.0 kg (396.0 pounds)

Reactions: Diarrhoea, Adverse Drug Reaction, Anaphylactic Shock, Dermatitis Exfoliative

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Savella
    Administration route: Oral
    Indication: Fibromyalgia
    Start date: 2011-09-07
    End date: 2011-09-07

Savella
    Administration route: Oral
    Start date: 2011-09-08
    End date: 2011-09-09

Savella
    Administration route: Oral
    Start date: 2011-09-10
    End date: 2011-09-12

Prilosec
    Administration route: Oral
    Start date: 2011-06-01

Torsemide
    Start date: 2011-07-13

Crestor
    Administration route: Oral
    Start date: 2011-06-01

Ibuprofen
    Start date: 2011-06-01

Lovaza
    Administration route: Oral
    Start date: 2011-09-07

Other drugs received by patient: Allopurinol; Propranolol; Amitriptyline HCL; Amoxicillin; Potassium Acetate; Metformin HCL; Multi-Vitamin; Cranberry; Synthroid; Lisinopril; Oxybutynin; Vicodin; Adipex-P; Glimepiride; Warfarin Sodium; Vitamin D; Cinnamon; Fenofibrate; Wellbutrin



Possible Torsemide side effects in male

Reported by a physician from Germany on 2012-06-06

Patient: male

Reactions: Loss of Consciousness

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Pantoprazole
    Administration route: Oral
    Indication: Gastric Disorder

Alfuzosin HCL
    Administration route: Oral
    Indication: Prostatic Disorder

Amitriptyline HCL
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Opium Alkaloids and Derivatives
    Indication: Ill-Defined Disorder

Opium / Naloxone TAB
    Indication: Pain

Bisoprolol Fumarate
    Administration route: Oral
    Indication: Hypertension

Voltaren
    Administration route: Oral
    Indication: Pain

Arcoxia
    Administration route: Oral
    Indication: Pain

Xarelto
    Administration route: Oral
    Indication: Knee Arthroplasty

Torsemide
    Administration route: Oral
    Indication: Diuretic Therapy

Amlodipine
    Administration route: Oral
    Indication: Hypertension

Ramipril
    Administration route: Oral
    Indication: Hypertension



Possible Torsemide side effects in female

Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-06-04

Patient: female

Reactions: International Normalised Ratio Increased

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Zofran
    Indication: Vomiting

Zofran
    Dosage: 12 mg
    Indication: Nausea
    Start date: 2012-02-15
    End date: 2012-03-04

Sintrom
    Dosage: 3 mg
    Administration route: Oral
    Indication: Atrial Fibrillation
    End date: 2012-02-20

Citalopram
    Dosage: 10 mg
    Administration route: Oral
    Indication: Depression

Torsemide
    Dosage: 10 mg
    Administration route: Oral

Other drugs received by patient: Laxoberon; Morphine; Digoxin; Vitamin D3 + Calcium TAB 500 MG; Floxapen; Digoxin; Lorazepam; Zolpidem



Possible Torsemide side effects in male

Reported by a physician from Germany on 2012-05-25

Patient: male

Reactions: Loss of Consciousness

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Xarelto
    Administration route: Oral
    Indication: Knee Arthroplasty

Voltaren
    Administration route: Oral
    Indication: Pain

Alfuzosin HCL
    Administration route: Oral
    Indication: Prostatic Disorder

Amitriptyline HCL
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Opium / Naloxone TAB
    Indication: Pain

Torsemide
    Administration route: Oral
    Indication: Diuretic Therapy

Amlodipine Besylate
    Administration route: Oral
    Indication: Hypertension

Pantoprazole
    Administration route: Oral
    Indication: Gastric Disorder

Arcoxia
    Administration route: Oral
    Indication: Pain

Bisoprolol Fumarate
    Administration route: Oral
    Indication: Hypertension

Ramipril
    Administration route: Oral
    Indication: Hypertension



Possible Torsemide side effects in female

Reported by a physician from Japan on 2012-05-25

Patient: female, weighing 50.0 kg (110.0 pounds)

Reactions: Activated Partial Thromboplastin Time Prolonged, Rectal Haemorrhage, International Normalised Ratio Increased, Rectal Ulcer, Blood Creatinine Increased, Melaena

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Trichlormethiazide
    Dosage: 1 mg
    Administration route: Oral
    Start date: 2012-03-02
    End date: 2012-04-18

Pradaxa
    Dosage: 220 mg
    Administration route: Oral
    Indication: Atrial Fibrillation
    Start date: 2012-03-30
    End date: 2012-04-18

Torsemide
    Dosage: 4 mg
    Administration route: Oral
    Start date: 2012-03-29
    End date: 2012-04-18

Etodolac
    Dosage: 400 mg
    Administration route: Oral
    Start date: 2012-03-07
    End date: 2012-04-18

Lasix
    Dosage: 4 mg
    Administration route: Oral
    Start date: 2012-03-02
    End date: 2012-04-18

Other drugs received by patient: Progogue D; Magnesium Oxide; Nexium; Depas; Rozerem; Rivastach; Norvasc



Possible Torsemide side effects in female

Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-05-21

Patient: female

Reactions: International Normalised Ratio Increased

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Sintrom
    Dosage: 3 mg
    Administration route: Oral
    Indication: Atrial Fibrillation
    End date: 2012-02-20

Zofran
    Dosage: 96 mg
    Indication: Nausea
    Start date: 2012-02-15
    End date: 2012-03-04

Torsemide
    Dosage: 10 mg
    Administration route: Oral

Sintrom
    Indication: Atrial Flutter

Zofran
    Indication: Vomiting

Citalopram Hydrobromide
    Dosage: 10 mg
    Administration route: Oral
    Indication: Depression

Other drugs received by patient: Lorazepam; Zolpidem; Vitamin D3 + Calcium TAB 500 MG; Floxapen; Digoxin; Morphine; Laxoberon; Digoxin



Possible Torsemide side effects in 84 year old female

Reported by a health professional (non-physician/pharmacist) from Switzerland on 2012-05-16

Patient: 84 year old female

Reactions: International Normalised Ratio Increased, Drug Interaction

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Citalopram Hydrobromide
    Administration route: Oral
    Indication: Depression

Zofran
    Indication: Nausea
    Start date: 2012-02-15
    End date: 2012-03-04

Zofran
    Indication: Vomiting

Torsemide
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Sintrom
    Administration route: Oral
    Indication: Atrial Fibrillation
    Start date: 2012-02-16
    End date: 2012-02-19

Other drugs received by patient: Temesta; Digoxin; Zolpidem; Laxoberon; Morphine; Colecalciferol; Floxapen



Possible Torsemide side effects in 83 year old female

Reported by a health professional (non-physician/pharmacist) from Switzerland on 2012-05-16

Patient: 83 year old female

Reactions: Vomiting, International Normalised Ratio Increased, Antibiotic Resistant Staphylococcus Test Positive, Constipation, Spondylitis, Anxiety, Sleep Disorder, Bacteraemia, Gastroenteritis Viral

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Sintrom
    Dosage: see image
    Administration route: Oral
    Indication: Atrial Flutter
    End date: 2012-02-20

Sintrom
    Dosage: see image
    Administration route: Oral
    Indication: Atrial Fibrillation
    End date: 2012-02-20

Citalopram Hydrobromide
    Dosage: prior taking 5 mg at home (10 mg,1 in 1 d),oral
    Administration route: Oral
    Indication: Depression

Zofran
    Dosage: 12 mg (4 mg,1 in 8 hr),intravenous drip
    Indication: Vomiting
    Start date: 2012-02-15
    End date: 2012-03-04

Zofran
    Dosage: 12 mg (4 mg,1 in 8 hr),intravenous drip
    Indication: Nausea
    Start date: 2012-02-15
    End date: 2012-03-04

Torsemide
    Dosage: 10 mg (10 mg,1 in 1 d),oral
    Administration route: Oral

Other drugs received by patient: Zolpidem; Floxapen (Flucloxacillin); Laxoberon (Sodium Picosulfate); Morphine HCL (Morphine Hydrochloride); Digoxin; Lorazepam; Calcimagon D3 (Colecalciferol, Calcium Carbonate)



Possible Torsemide side effects in female

Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-05-14

Patient: female

Reactions: International Normalised Ratio Increased

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Citalopram Hydrobromide
    Dosage: 10 mg
    Administration route: Oral
    Indication: Depression

Sintrom
    Dosage: 3 mg
    Administration route: Oral
    Indication: Atrial Fibrillation
    End date: 2012-02-20

Zofran
    Dosage: 96 mg
    Indication: Nausea
    Start date: 2012-02-15
    End date: 2012-03-04

Zofran
    Indication: Vomiting

Torsemide
    Dosage: 10 mg
    Administration route: Oral

Sintrom
    Indication: Atrial Flutter

Other drugs received by patient: Floxapen; Digoxin; Temesta; Zolpidem; Digoxin; Morphine; Vitamin D3 + Calcium TAB 500 MG; Laxoberon



Possible Torsemide side effects in 83 year old female

Reported by a health professional (non-physician/pharmacist) from Switzerland on 2012-05-08

Patient: 83 year old female

Reactions: Vomiting, Nausea, Bacteraemia, Staphylococcal Infection, International Normalised Ratio Increased, Gastroenteritis Viral, Spondylitis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Zofran
    Indication: Vomiting

Citalopram Hydrobromide
    Dosage: 10 mg, daily dose, long term
    Administration route: Oral

Zofran
    Dosage: 4 mg, per 8 hours
    Indication: Nausea
    Start date: 2012-02-15
    End date: 2012-03-04

Torsemide
    Dosage: 10 mg, daily dose, long term
    Administration route: Oral

Sintrom
    Dosage: 3 mg, daily
    Administration route: Oral
    Indication: Atrial Fibrillation
    End date: 2012-02-20

Other drugs received by patient: Floxapen; Digoxin; Calcimagon-D3; Morphin HCL; Zolpidem; Laxoberon; Digoxin



Possible Torsemide side effects in 83 year old female

Reported by a physician from Switzerland on 2012-05-07

Patient: 83 year old female

Reactions: International Normalised Ratio Increased

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Citalopram Hydrobromide
    Dosage: 10mg per day
    Administration route: Oral
    Indication: Depression

Sintrom
    Dosage: 3mg per day
    Administration route: Oral
    Indication: Arrhythmia Supraventricular
    End date: 2012-02-20

Torsemide
    Dosage: 10mg per day
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Zofran
    Dosage: 4mg three times per day
    Indication: Nausea
    Start date: 2012-02-15
    End date: 2012-03-04

Other drugs received by patient: Digoxin; Zolpidem; Floxapen; Morphine; Laxoberon; Lorazepam; Calcimagon-D3



Possible Torsemide side effects in 69 year old male

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-04-23

Patient: 69 year old male

Reactions: Circulatory Collapse, Drug Interaction

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Torsemide
    Dosage: 10 mg, unk
    Administration route: Oral
    Indication: Cardiac Failure
    Start date: 2006-01-01
    End date: 2008-07-14

Xipamide
    Dosage: 40 mg, 1x/day
    Administration route: Oral
    Indication: Cardiac Failure
    Start date: 2008-06-24
    End date: 2008-07-09

Other drugs received by patient possibly interacting with the suspect drug:
Ramipril
    Dosage: 2.5 mg, 2x/day
    Administration route: Oral
    Indication: Hypertension
    Start date: 2007-01-01
    End date: 2008-07-14

Bisobloc
    Dosage: 2.5 mg, 1x/day
    Administration route: Oral
    Indication: Angina Pectoris
    Start date: 2003-01-01

Ramipril
    Dosage: unk
    Start date: 2008-07-23

Other drugs received by patient: Insuman Comb 25; Clopidogrel Bisulfate; Acetylsalicylic Acid; Simvastatin



Possible Torsemide side effects in 69 year old male

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-04-20

Patient: 69 year old male

Reactions: Drug Interaction, Circulatory Collapse

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Xipamide
    Dosage: 40 mg, 1x/day
    Administration route: Oral
    Indication: Cardiac Failure
    Start date: 2008-06-24
    End date: 2008-07-09

Torsemide
    Dosage: 10 mg, unk
    Administration route: Oral
    Indication: Cardiac Failure
    Start date: 2006-01-01
    End date: 2008-07-14

Other drugs received by patient possibly interacting with the suspect drug:
Ramipril
    Dosage: 2.5 mg, 2x/day
    Administration route: Oral
    Indication: Hypertension
    Start date: 2007-01-01
    End date: 2008-07-14

Bisoprolol Fumarate
    Dosage: 2.5 mg, 1x/day
    Administration route: Oral
    Indication: Angina Pectoris
    Start date: 2003-01-01

Ramipril
    Dosage: unk

Other drugs received by patient: Acetylsalicylic Acid; Simvastatin; Clopidogrel Bisulfate; Insuman Comb 25



Possible Torsemide side effects in 87 year old female

Reported by a physician from Japan on 2012-03-29

Patient: 87 year old female

Reactions: Poor Peripheral Circulation, LEG Amputation

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Torsemide
    Administration route: Oral
    Indication: Oedema
    Start date: 2010-12-06
    End date: 2010-12-24

Sarpogrelate
    Administration route: Oral
    Indication: Peripheral Arterial Occlusive Disease
    Start date: 2010-11-23

Amlodipine Besylate
    Administration route: Oral
    Indication: Hypertension

Other drugs received by patient: Alprostadil; Dorner; Pletal



Possible Torsemide side effects in 87 year old female

Reported by a physician from Japan on 2012-03-29

Patient: 87 year old female

Reactions: Vascular Insufficiency, Drug Ineffective, Oedema, Condition Aggravated, LEG Amputation, Hypertension

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Torsemide
    Dosage: 8 mg (8 mg, 1 in 1 d), oral
    Administration route: Oral
    Indication: Oedema
    Start date: 2010-12-06
    End date: 2010-12-24

Norvasc
    Dosage: (7.5 mg), oral
    Administration route: Oral
    Indication: Hypertension

Anplag (Sarpogrelate Hydrochloride)
    Dosage: (300 mg), oral
    Administration route: Oral
    Indication: Peripheral Arterial Occlusive Disease
    Start date: 2010-11-23

Other drugs received by patient: Alprostadil; Pletal; Dorner (Beraprostsodium)



Possible Torsemide side effects in male

Reported by a physician from Germany on 2012-03-22

Patient: male, weighing 94.0 kg (206.8 pounds)

Reactions: Intracardiac Thrombus, Left Ventricular Failure, Hypertensive Crisis, Infection

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Torsemide
    Dosage: 7.5 mg, daily
    Administration route: Oral
    Indication: Cardiac Failure
    Start date: 2008-01-01

Procoralan
    Dosage: 10 mg, daily
    Administration route: Oral
    Indication: Cardiac Failure
    Start date: 2011-01-01

Rasilez
    Administration route: Oral
    Indication: Hypertension

Falithrom
    Dosage: 3 mg, daily
    Administration route: Oral
    Indication: Thrombophlebitis Superficial
    Start date: 2009-01-01

Diovan HCT
    Dosage: 80 /25 mg, daily
    Indication: Cardiac Failure
    Start date: 2008-01-01

Fluvastatin Sodium
    Dosage: 30 mg, daily
    Administration route: Oral
    Indication: Hyperlipidaemia
    Start date: 2008-01-01

Glimepiride
    Dosage: 4 mg , daily
    Administration route: Oral
    Indication: Diabetes Mellitus
    Start date: 2008-01-01

Bisoprolol Fumarate
    Dosage: 7.5 mg, daily
    Administration route: Oral
    Indication: Coronary Artery Disease
    Start date: 2008-01-01

Rasilez
    Dosage: 150 mg, daily
    End date: 2012-01-17

Diovan HCT
    Dosage: 160 /25 mg, daily

Diovan HCT
    Dosage: 320/25 mg, daily

Metformin HCL
    Dosage: 2000 mg, daily
    Start date: 2008-01-01

Other drugs received by patient: Platelet Aggregation Inhibitors; Thienopyridine; Anticoagulants



Possible Torsemide side effects in male

Reported by a physician from Germany on 2012-03-22

Patient: male, weighing 94.0 kg (206.8 pounds)

Reactions: Left Ventricular Failure, Intracardiac Thrombus, Hypertensive Crisis, Infection

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Diovan HCT
    Dosage: 80 /25 mg, daily
    Indication: Cardiac Failure
    Start date: 2008-01-01

Procoralan
    Dosage: 10 mg, daily
    Administration route: Oral
    Indication: Cardiac Failure
    Start date: 2011-01-01

Falithrom
    Dosage: 3 mg, daily
    Administration route: Oral
    Indication: Thrombophlebitis Superficial
    Start date: 2009-01-01

Rasilez
    Administration route: Oral
    Indication: Hypertension

Fluvastatin Sodium
    Dosage: 30 mg, daily
    Administration route: Oral
    Indication: Hyperlipidaemia
    Start date: 2008-01-01

Torsemide
    Dosage: 7.5 mg, daily
    Administration route: Oral
    Indication: Cardiac Failure
    Start date: 2008-01-01

Glimepiride
    Dosage: 4 mg , daily
    Administration route: Oral
    Indication: Diabetes Mellitus
    Start date: 2008-01-01

Metformin HCL
    Dosage: 2000 mg, daily
    Start date: 2008-01-01

Diovan HCT
    Dosage: 320/25 mg, daily

Bisoprolol Fumarate
    Dosage: 7.5 mg, daily
    Administration route: Oral
    Indication: Coronary Artery Disease
    Start date: 2008-01-01

Rasilez
    Dosage: 150 mg, daily
    End date: 2012-01-17

Diovan HCT
    Dosage: 160 /25 mg, daily

Other drugs received by patient: Platelet Aggregation Inhibitors; Thienopyridine; Anticoagulants



Possible Torsemide side effects in 87 year old female

Reported by a physician from Japan on 2012-03-19

Patient: 87 year old female

Reactions: Poor Peripheral Circulation, LEG Amputation

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Sarpogrelate
    Administration route: Oral
    Indication: Peripheral Arterial Occlusive Disease
    Start date: 2010-11-23

Amlodipine Besylate
    Administration route: Oral
    Indication: Hypertension

Torsemide
    Administration route: Oral
    Indication: Oedema
    Start date: 2010-12-06
    End date: 2010-12-24

Other drugs received by patient: Dorner; Pletal; Alprostadil



Possible Torsemide side effects in male

Reported by a physician from Germany on 2012-03-14

Patient: male, weighing 94.0 kg (206.8 pounds)

Reactions: Coronary Artery Thrombosis, Left Ventricular Failure, Hypertensive Crisis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Rasilez
    Administration route: Oral
    Indication: Hypertension

Fluvastatin Sodium
    Dosage: 30 mg, daily
    Administration route: Oral
    Indication: Hyperlipidaemia
    Start date: 2008-01-01

Procoralan
    Dosage: 10 mg, daily
    Administration route: Oral
    Indication: Cardiac Failure
    Start date: 2011-01-01

Falithrom
    Dosage: 3 mg, daily
    Administration route: Oral
    Indication: Thrombophlebitis Superficial
    Start date: 2009-01-01

Diovan HCT
    Dosage: 80 /25 mg, daily
    Indication: Cardiac Failure
    Start date: 2008-01-01

Diovan HCT
    Dosage: 160 /25 mg, daily

Bisoprolol Fumarate
    Dosage: 7.5 mg, daily
    Administration route: Oral
    Indication: Coronary Artery Disease
    Start date: 2008-01-01

Rasilez
    Dosage: 150 mg, daily
    End date: 2012-01-17

Diovan HCT
    Dosage: 320/25 mg, daily

Metformin HCL
    Dosage: 2000 mg, daily
    Start date: 2008-01-01

Torsemide
    Dosage: 7.5 mg, daily
    Administration route: Oral
    Indication: Cardiac Failure
    Start date: 2008-01-01

Glimepiride
    Dosage: 4 mg , daily
    Administration route: Oral
    Indication: Diabetes Mellitus
    Start date: 2008-01-01

Other drugs received by patient: Platelet Aggregation Inhibitors; Thienopyridine; Anticoagulants



Possible Torsemide side effects in male

Reported by a physician from Germany on 2012-03-14

Patient: male, weighing 94.0 kg (206.8 pounds)

Reactions: Coronary Artery Thrombosis, Left Ventricular Failure, Hypertensive Crisis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Rasilez
    Administration route: Oral
    Indication: Hypertension

Metformin HCL
    Dosage: 2000 mg, daily
    Start date: 2008-01-01

Rasilez
    Dosage: 150 mg, daily
    End date: 2012-01-17

Diovan HCT
    Dosage: 320/25 mg, daily

Falithrom
    Dosage: 3 mg, daily
    Administration route: Oral
    Indication: Thrombophlebitis Superficial
    Start date: 2009-01-01

Fluvastatin Sodium
    Dosage: 30 mg, daily
    Administration route: Oral
    Indication: Hyperlipidaemia
    Start date: 2008-01-01

Torsemide
    Dosage: 7.5 mg, daily
    Administration route: Oral
    Indication: Cardiac Failure
    Start date: 2008-01-01

Diovan HCT
    Dosage: 160 /25 mg, daily

Procoralan
    Dosage: 10 mg, daily
    Administration route: Oral
    Indication: Cardiac Failure
    Start date: 2011-01-01

Diovan HCT
    Dosage: 80 /25 mg, daily
    Indication: Cardiac Failure
    Start date: 2008-01-01

Glimepiride
    Dosage: 4 mg , daily
    Administration route: Oral
    Indication: Diabetes Mellitus
    Start date: 2008-01-01

Bisoprolol Fumarate
    Dosage: 7.5 mg, daily
    Administration route: Oral
    Indication: Coronary Artery Disease
    Start date: 2008-01-01

Other drugs received by patient: Thienopyridine; Platelet Aggregation Inhibitors; Anticoagulants



Possible Torsemide side effects in 87 year old female

Reported by a physician from Japan on 2012-03-13

Patient: 87 year old female

Reactions: Intermittent Claudication, Pain, Oedema, Hypoaesthesia, LEG Amputation, Gait Disturbance, Feeling Cold

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Anplag (Sarpogrelate Hydrochloride)
    Dosage: (300 m), oral
    Administration route: Oral
    Indication: Peripheral Arterial Occlusive Disease
    Start date: 2010-11-23

Torsemide
    Dosage: 8 mg (8 mg, 1 in 1 d), oral
    Administration route: Oral
    Indication: Oedema
    Start date: 2010-12-06
    End date: 2010-12-24

Norvasc
    Dosage: (7.5 mg), oral
    Administration route: Oral
    Indication: Hypertension

Other drugs received by patient: Pletal; Dorner (Beraprost Sodium); Paulux (Alprostadil)



Possible Torsemide side effects in female

Reported by a physician from Germany on 2012-02-23

Patient: female, weighing 75.0 kg (165.0 pounds)

Reactions: Metabolic Acidosis, Urine Output Decreased, Oedema, Renal Failure Acute

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Rasilez
    Dosage: 300 mg, qd
    Administration route: Oral
    Indication: Hypertension
    End date: 2011-11-07

Torsemide
    Dosage: 10 mg, per day
    Administration route: Oral
    Indication: Hypertension

Ramipril
    Dosage: 10 mg, per day
    Administration route: Oral
    Indication: Hypertension

Other drugs received by patient: Tramadol HCL; Amlodipine; Novalgin; Simvastatin



Possible Torsemide side effects in male

Reported by a physician from Germany on 2012-02-08

Patient: male, weighing 90.0 kg (198.0 pounds)

Reactions: Shock Haemorrhagic, Disseminated Intravascular Coagulation, Haematoma

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Pradaxa
    Indication: Cerebral Infarction

Bisoprolol
    Dosage: 50 mg
    Administration route: Oral
    Indication: Coronary Artery Disease
    Start date: 2002-01-01

Bisoprolol
    Indication: Hypertension

Aspirin
    Dosage: 100 mg
    Administration route: Oral
    Indication: Coronary Artery Disease
    Start date: 2002-01-01
    End date: 2012-01-22

Ramipril
    Dosage: 10 mg
    Administration route: Oral
    Indication: Hypertension
    Start date: 2002-01-01

Pradaxa
    Dosage: 220 mg
    Administration route: Oral
    Indication: Atrial Fibrillation
    Start date: 2011-10-19
    End date: 2012-01-22

Aspirin
    Indication: Myocardial Infarction

Bayotensin
    Dosage: 20 mg
    Administration route: Oral
    Indication: Coronary Artery Disease
    End date: 2012-01-22

Simvastatin
    Dosage: 40 mg
    Administration route: Oral
    Indication: Hyperlipidaemia
    End date: 2012-01-22

Bayotensin
    Indication: Hypertension

Torsemide
    Dosage: 5 mg
    Administration route: Oral
    Indication: Hypertension
    End date: 2012-01-22

Aspirin
    Indication: Coronary Artery Bypass



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014